[
  {
    "ts": "2025-11-14T00:37:00+00:00",
    "headline": "Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs",
    "summary": "Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (‚ÄúMangoceuticals‚Äù or the ‚ÄúCompany‚Äù) is issuing the following clarification regarding its press release issued earlier this morning titled ‚ÄúMangoceuticals Partners with Eli Lilly and Novo Nordisk‚Ä¶‚Äù. The newly launched Mangoceuticals weight-management programs MangoRx Direct and PeachesRx Direct are licensed and approved to issue, through a third-party provider, valid prescriptions for FDA-approved branded GLP-1 m",
    "url": "https://finance.yahoo.com/news/mangoceuticals-provides-clarification-launch-branded-003700946.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "6159aeb4-4799-337e-b343-f892b6303057",
      "content": {
        "id": "6159aeb4-4799-337e-b343-f892b6303057",
        "contentType": "STORY",
        "title": "Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs",
        "description": "",
        "summary": "Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (‚ÄúMangoceuticals‚Äù or the ‚ÄúCompany‚Äù) is issuing the following clarification regarding its press release issued earlier this morning titled ‚ÄúMangoceuticals Partners with Eli Lilly and Novo Nordisk‚Ä¶‚Äù. The newly launched Mangoceuticals weight-management programs MangoRx Direct and PeachesRx Direct are licensed and approved to issue, through a third-party provider, valid prescriptions for FDA-approved branded GLP-1 m",
        "pubDate": "2025-11-14T00:37:00Z",
        "displayTime": "2025-11-14T00:37:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/94775c7523023e222b2a19fc37cc02ca",
          "originalWidth": 8000,
          "originalHeight": 4500,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XnuNJ9Qe6ko.i5UiATBWRA--~B/aD00NTAwO3c9ODAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/94775c7523023e222b2a19fc37cc02ca.cf.webp",
              "width": 8000,
              "height": 4500,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Yet6sa3uxTjLL1d634T49w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/94775c7523023e222b2a19fc37cc02ca.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/mangoceuticals-provides-clarification-launch-branded-003700946.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/mangoceuticals-provides-clarification-launch-branded-003700946.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MGRX"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T06:15:00+00:00",
    "headline": "Netflix‚Äôs Stock Split Is Almost Here. Eli Lilly Could Be Next.",
    "summary": "The drugmaker‚Äôs stock checks all the boxes for a split. the price keeps climbing, the company is on fire, and it‚Äôs a bull market.",
    "url": "https://www.barrons.com/articles/stock-split-netflix-eli-lilly-a586f249?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "b5559cb6-8619-32fb-8c93-df686d8c3da9",
      "content": {
        "id": "b5559cb6-8619-32fb-8c93-df686d8c3da9",
        "contentType": "STORY",
        "title": "Netflix‚Äôs Stock Split Is Almost Here. Eli Lilly Could Be Next.",
        "description": "",
        "summary": "The drugmaker‚Äôs stock checks all the boxes for a split. the price keeps climbing, the company is on fire, and it‚Äôs a bull market.",
        "pubDate": "2025-11-14T06:15:00Z",
        "displayTime": "2025-11-14T06:15:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/b5559cb6-8619-32fb-8c93-df686d8c3da9/netflix%E2%80%99s-stock-split-is.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/365ba1362c97d42416b3158eac8a1797",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GICue7yKKdDoZeWd0HbwjQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/365ba1362c97d42416b3158eac8a1797.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AyMkZ6h2u8WMtBUX0EK4Iw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/365ba1362c97d42416b3158eac8a1797.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/stock-split-netflix-eli-lilly-a586f249?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NFLX"
            },
            {
              "symbol": "AAPL"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T08:00:00+00:00",
    "headline": "Medicxi Announces ‚Ç¨500 Million Fund V",
    "summary": "Medicxi, a leading European life sciences venture capital firm, today announced the closing of Medicxi V, a ‚Ç¨500 million fund dedicated to building and backing innovative biotechnology companies with clear product visions to transform patient care. The oversubscribed fund closed with strong support from existing limited partners and a select group of new institutional investors. The Fund will focus on Medicxi's pioneering asset-centric investment model.",
    "url": "https://finance.yahoo.com/news/medicxi-announces-500-million-fund-080000306.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "15a49308-e051-3ea0-ba9b-c9e499a6d194",
      "content": {
        "id": "15a49308-e051-3ea0-ba9b-c9e499a6d194",
        "contentType": "STORY",
        "title": "Medicxi Announces ‚Ç¨500 Million Fund V",
        "description": "",
        "summary": "Medicxi, a leading European life sciences venture capital firm, today announced the closing of Medicxi V, a ‚Ç¨500 million fund dedicated to building and backing innovative biotechnology companies with clear product visions to transform patient care. The oversubscribed fund closed with strong support from existing limited partners and a select group of new institutional investors. The Fund will focus on Medicxi's pioneering asset-centric investment model.",
        "pubDate": "2025-11-14T08:00:00Z",
        "displayTime": "2025-11-14T08:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/c75b9bd6cf5986d3134896c7f127f3e2",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VuDuVP_.IF9RUa0p9thvqw--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/c75b9bd6cf5986d3134896c7f127f3e2.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CZeTaFdpoqArgqmV00I8Gg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/c75b9bd6cf5986d3134896c7f127f3e2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/medicxi-announces-500-million-fund-080000306.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/medicxi-announces-500-million-fund-080000306.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABVX.PA"
            },
            {
              "symbol": "PCVX"
            },
            {
              "symbol": "SAN.PA"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "GMAB.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T11:15:00+00:00",
    "headline": "Why Is Everyone Talking About Novo Nordisk Stock?",
    "summary": "There is hardly a dull moment for the drugmaker these days.",
    "url": "https://www.fool.com/investing/2025/11/14/why-is-everyone-talking-about-novo-nordisk-stock/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "e52c5425-ada0-3243-a470-27eb124e82c8",
      "content": {
        "id": "e52c5425-ada0-3243-a470-27eb124e82c8",
        "contentType": "STORY",
        "title": "Why Is Everyone Talking About Novo Nordisk Stock?",
        "description": "",
        "summary": "There is hardly a dull moment for the drugmaker these days.",
        "pubDate": "2025-11-14T11:15:00Z",
        "displayTime": "2025-11-14T11:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/ada7dbe0c44490944adaf52154be74bc",
          "originalWidth": 1400,
          "originalHeight": 934,
          "caption": "Person sitting at a desk looking at two monitors displaying stock charts.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9KqCntdyogqdrXiCISkQPQ--~B/aD05MzQ7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/ada7dbe0c44490944adaf52154be74bc.cf.webp",
              "width": 1400,
              "height": 934,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3ic3He1fwJebVPIz2j5tOA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/ada7dbe0c44490944adaf52154be74bc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/14/why-is-everyone-talking-about-novo-nordisk-stock/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-everyone-talking-novo-nordisk-111500612.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T13:00:41+00:00",
    "headline": "Eli Lilly and Novo Nordisk disown Mangoceuticals‚Äô GLP-1RA partnership claim",
    "summary": "The two drugmakers swiftly denied any affiliation with Mangoceuticals, who claimed it had partnered with them.",
    "url": "https://www.pharmaceutical-technology.com/news/eli-lilly-and-novo-nordisk-disown-mangoceuticals-glp-1ra-partnership-claim/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "7af73c08-09de-3221-acf5-d305e3d973d7",
      "content": {
        "id": "7af73c08-09de-3221-acf5-d305e3d973d7",
        "contentType": "STORY",
        "title": "Eli Lilly and Novo Nordisk disown Mangoceuticals‚Äô GLP-1RA partnership claim",
        "description": "",
        "summary": "The two drugmakers swiftly denied any affiliation with Mangoceuticals, who claimed it had partnered with them.",
        "pubDate": "2025-11-14T13:00:41Z",
        "displayTime": "2025-11-14T13:00:41Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/adcf11295754199b76bf5e0a8d4bb683",
          "originalWidth": 1000,
          "originalHeight": 444,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/coUAeaSseFvlAsf_Euc_pw--~B/aD00NDQ7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/adcf11295754199b76bf5e0a8d4bb683.cf.webp",
              "width": 1000,
              "height": 444,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sMVWuvArsWHIbkAt20.wDg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/adcf11295754199b76bf5e0a8d4bb683.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/eli-lilly-and-novo-nordisk-disown-mangoceuticals-glp-1ra-partnership-claim/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-novo-nordisk-disown-130041879.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "MGRX"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T12:59:00+00:00",
    "headline": "Pharma ETFs in Spotlight Following Robust Q3 Earnings Results",
    "summary": "Pharma ETFs like IHE and PPH are rallying as strong Q3 earnings across major pharmaceutical companies lift sector sentiment.",
    "url": "https://finance.yahoo.com/news/pharma-etfs-spotlight-following-robust-125900300.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "10fc0cfd-b499-32b5-907f-5817647b3297",
      "content": {
        "id": "10fc0cfd-b499-32b5-907f-5817647b3297",
        "contentType": "STORY",
        "title": "Pharma ETFs in Spotlight Following Robust Q3 Earnings Results",
        "description": "",
        "summary": "Pharma ETFs like IHE and PPH are rallying as strong Q3 earnings across major pharmaceutical companies lift sector sentiment.",
        "pubDate": "2025-11-14T12:59:00Z",
        "displayTime": "2025-11-14T12:59:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/780f3ed4ed0b380d687c52a84b4582b8",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/F9Duz3IXY6vI3GQX0iFRbg--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/780f3ed4ed0b380d687c52a84b4582b8.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jvXjFQvI33DlpnQwQb.s8g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/780f3ed4ed0b380d687c52a84b4582b8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pharma-etfs-spotlight-following-robust-125900300.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pharma-etfs-spotlight-following-robust-125900300.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PJP"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "XPH"
            },
            {
              "symbol": "FTXH"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "IHE"
            },
            {
              "symbol": "PPH"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T12:37:00+00:00",
    "headline": "Zacks Investment Ideas feature highlights: IWM, CoreWeave, Astera Labs, Nebius, Expand Energy, Eli Lilly and Nvidia",
    "summary": "Zacks Investment Ideas tracks market shifts as IWM strength, AI stock rotation and Nvidia's key support test shape year-end positioning.",
    "url": "https://finance.yahoo.com/news/zacks-investment-ideas-feature-highlights-123700372.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "510245e2-6819-35ac-92d0-c0d25fbac723",
      "content": {
        "id": "510245e2-6819-35ac-92d0-c0d25fbac723",
        "contentType": "STORY",
        "title": "Zacks Investment Ideas feature highlights: IWM, CoreWeave, Astera Labs, Nebius, Expand Energy, Eli Lilly and Nvidia",
        "description": "",
        "summary": "Zacks Investment Ideas tracks market shifts as IWM strength, AI stock rotation and Nvidia's key support test shape year-end positioning.",
        "pubDate": "2025-11-14T12:37:00Z",
        "displayTime": "2025-11-14T12:37:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MjuR.4zEKm0FgKsxK.lBKQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/G.VCDKzJSEg_sv.1sSAJrQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/zacks-investment-ideas-feature-highlights-123700372.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/zacks-investment-ideas-feature-highlights-123700372.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "IWM"
            },
            {
              "symbol": "ALAB"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "CRWV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T15:53:50+00:00",
    "headline": "Novo Chairman Blames Board Dropout on Former Employer Pfizer",
    "summary": "The executive, who brought Novo‚Äôs first weight-loss shot to market, had to spend part of the meeting explaining why proposed board member, Mikael Dolsten, 67, withdrew just a day ago because of an ‚Äúissue with a former employer.‚Äù  ‚ÄúWe had very much looked forward to working together with Mikael Dolsten,‚Äù Sorensen said.  Pfizer‚Äôs acquisition of Metsera closed on Thursday making Novo and its US rival clear competitors in the hottest and fastest-growing pharmaceutical market.",
    "url": "https://finance.yahoo.com/news/novo-chairman-urged-curb-risk-050000756.html",
    "source": "Bloomberg",
    "provider": "yfinance",
    "raw": {
      "id": "33199485-1b91-3453-ad37-b168daa959a1",
      "content": {
        "id": "33199485-1b91-3453-ad37-b168daa959a1",
        "contentType": "STORY",
        "title": "Novo Chairman Blames Board Dropout on Former Employer Pfizer",
        "description": "",
        "summary": "The executive, who brought Novo‚Äôs first weight-loss shot to market, had to spend part of the meeting explaining why proposed board member, Mikael Dolsten, 67, withdrew just a day ago because of an ‚Äúissue with a former employer.‚Äù  ‚ÄúWe had very much looked forward to working together with Mikael Dolsten,‚Äù Sorensen said.  Pfizer‚Äôs acquisition of Metsera closed on Thursday making Novo and its US rival clear competitors in the hottest and fastest-growing pharmaceutical market.",
        "pubDate": "2025-11-14T15:53:50Z",
        "displayTime": "2025-11-14T15:53:50Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/bloomberg_holding_pen_162/5048dbfd6dc03232007cca42e59d5d74",
          "originalWidth": 1600,
          "originalHeight": 1067,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yyImDYGgGcKqsHHca7ayeQ--~B/aD0xMDY3O3c9MTYwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/bloomberg_holding_pen_162/5048dbfd6dc03232007cca42e59d5d74.cf.webp",
              "width": 1600,
              "height": 1067,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/s_i5swtQx0TdQo8H5RNH5w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/bloomberg_holding_pen_162/5048dbfd6dc03232007cca42e59d5d74.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Bloomberg",
          "url": "https://www.bloomberg.com/company"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novo-chairman-urged-curb-risk-050000756.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-chairman-urged-curb-risk-050000756.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T13:53:00+00:00",
    "headline": "Can Lilly's Next-Gen Obesity Drugs Help Sustain Its Market Dominance?",
    "summary": "Eli Lilly's next-gen obesity drugs, led by oral orforglipron and triple-acting retatrutide, aim to reshape the fast-growing weight-loss market.",
    "url": "https://finance.yahoo.com/news/lillys-next-gen-obesity-drugs-135300254.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "e47da764-220b-3389-a0ed-62f552859d67",
      "content": {
        "id": "e47da764-220b-3389-a0ed-62f552859d67",
        "contentType": "STORY",
        "title": "Can Lilly's Next-Gen Obesity Drugs Help Sustain Its Market Dominance?",
        "description": "",
        "summary": "Eli Lilly's next-gen obesity drugs, led by oral orforglipron and triple-acting retatrutide, aim to reshape the fast-growing weight-loss market.",
        "pubDate": "2025-11-14T13:53:00Z",
        "displayTime": "2025-11-14T13:53:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/08c70fc44d9b8340859581d38311e071",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JLDGQt80ARh3qkafoo9TaA--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/08c70fc44d9b8340859581d38311e071.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ncdWYZW_rP_HUKWXjdodfA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/08c70fc44d9b8340859581d38311e071.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/lillys-next-gen-obesity-drugs-135300254.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/lillys-next-gen-obesity-drugs-135300254.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T16:35:51+00:00",
    "headline": "Stocks to Watch Friday: Walmart, Eli Lilly, Warner Bros.",
    "summary": "‚ÜòÔ∏è Walmart (WMT): Chief Executive Doug McMillon is retiring after more than 15 years with the U.S.'s largest retailer. Shares fell more than 1%. ‚ÜóÔ∏è Eli Lilly (LLY): The drugmaker's shares edged higher, pushing it closer to the $1 trillion market capitalization milestone.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-11-14-2025/card/stocks-to-watch-friday-applied-materials-nvidia-warner-bros--u4Yrx3bIUdt4HrktoRLp?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "61736e40-a7b9-3740-9c5c-f8ea7c76b1ed",
      "content": {
        "id": "61736e40-a7b9-3740-9c5c-f8ea7c76b1ed",
        "contentType": "STORY",
        "title": "Stocks to Watch Friday: Walmart, Eli Lilly, Warner Bros.",
        "description": "",
        "summary": "‚ÜòÔ∏è Walmart (WMT): Chief Executive Doug McMillon is retiring after more than 15 years with the U.S.'s largest retailer. Shares fell more than 1%. ‚ÜóÔ∏è Eli Lilly (LLY): The drugmaker's shares edged higher, pushing it closer to the $1 trillion market capitalization milestone.",
        "pubDate": "2025-11-14T16:35:51Z",
        "displayTime": "2025-11-14T16:35:51Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/61736e40-a7b9-3740-9c5c-f8ea7c76b1ed/stocks-to-watch-friday-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/3cd87e4655c7a6f84655b734289e98db",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DuZVMMPCCm1AnTmbyP9ikQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/3cd87e4655c7a6f84655b734289e98db.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1zGwFFg0M3XpqvUvCEkyzA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/3cd87e4655c7a6f84655b734289e98db.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-11-14-2025/card/stocks-to-watch-friday-applied-materials-nvidia-warner-bros--u4Yrx3bIUdt4HrktoRLp?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WMT"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "WBD"
            },
            {
              "symbol": "CDTX"
            },
            {
              "symbol": "CMCSA"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "AMAT"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "MSFT"
            }
          ],
          "premiumFinance": null
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T17:56:43+00:00",
    "headline": "Eli Lilly Leads Three Stocks Near Buy Points",
    "summary": "The stock market continued its sell-off Friday, but a few stocks ascended in buy zones and hovered near new highs.  Eli¬† Lilly, for one, hit an all-time high.  Another is Valero, which has edged into a buy zone above an entry at 178.43, according to IBD MarketSurge.",
    "url": "https://www.investors.com/stock-lists/new-highs/eli-lilly-stock-lly/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "e5014199-0635-300c-a9ba-be0128613f9d",
      "content": {
        "id": "e5014199-0635-300c-a9ba-be0128613f9d",
        "contentType": "STORY",
        "title": "Eli Lilly Leads Three Stocks Near Buy Points",
        "description": "",
        "summary": "The stock market continued its sell-off Friday, but a few stocks ascended in buy zones and hovered near new highs.  Eli¬† Lilly, for one, hit an all-time high.  Another is Valero, which has edged into a buy zone above an entry at 178.43, according to IBD MarketSurge.",
        "pubDate": "2025-11-14T17:56:43Z",
        "displayTime": "2025-11-14T17:56:43Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/e5014199-0635-300c-a9ba-be0128613f9d/eli-lilly-leads-three-stocks.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/1d988fec8a7a7d0d55f7efa41a259447",
          "originalWidth": 945,
          "originalHeight": 533,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/d1xcBEHzBWI9KuCB23.YfA--~B/aD01MzM7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/1d988fec8a7a7d0d55f7efa41a259447.cf.webp",
              "width": 945,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0OXmk.TxNEPuSPIBuwUJ.g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/1d988fec8a7a7d0d55f7efa41a259447.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/stock-lists/new-highs/eli-lilly-stock-lly/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "RPRX"
            },
            {
              "symbol": "VLO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T16:35:51+00:00",
    "headline": "Stocks to Watch Friday: Walmart, Eli Lilly,  Under Armour, Warner Bros.",
    "summary": "‚ÜòÔ∏è Walmart (WMT): Chief Executive Doug McMillon is retiring after more than 15 years with the U.S.'s largest retailer. Shares fell 1% in midday trading. ‚ÜóÔ∏è Rocket Lab (RKLB): SpaceX rival Blue Origin launched its first NASA mission, deploying two Rocket Lab-made satellites that will fly to Mars (üìπ watch the video).",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-11-14-2025/card/stocks-to-watch-friday-applied-materials-nvidia-warner-bros--u4Yrx3bIUdt4HrktoRLp?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "61736e40-a7b9-3740-9c5c-f8ea7c76b1ed",
      "content": {
        "id": "61736e40-a7b9-3740-9c5c-f8ea7c76b1ed",
        "contentType": "STORY",
        "title": "Stocks to Watch Friday: Walmart, Eli Lilly,  Under Armour, Warner Bros.",
        "description": "",
        "summary": "‚ÜòÔ∏è Walmart (WMT): Chief Executive Doug McMillon is retiring after more than 15 years with the U.S.'s largest retailer. Shares fell 1% in midday trading. ‚ÜóÔ∏è Rocket Lab (RKLB): SpaceX rival Blue Origin launched its first NASA mission, deploying two Rocket Lab-made satellites that will fly to Mars (üìπ watch the video).",
        "pubDate": "2025-11-14T16:35:51Z",
        "displayTime": "2025-11-14T16:35:51Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/61736e40-a7b9-3740-9c5c-f8ea7c76b1ed/stocks-to-watch-friday-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/3cd87e4655c7a6f84655b734289e98db",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DuZVMMPCCm1AnTmbyP9ikQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/3cd87e4655c7a6f84655b734289e98db.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1zGwFFg0M3XpqvUvCEkyzA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/3cd87e4655c7a6f84655b734289e98db.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-11-14-2025/card/stocks-to-watch-friday-applied-materials-nvidia-warner-bros--u4Yrx3bIUdt4HrktoRLp?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WMT"
            },
            {
              "symbol": "WBD"
            },
            {
              "symbol": "UA"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "UAA"
            },
            {
              "symbol": "AMAT"
            },
            {
              "symbol": "CMCSA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T18:31:13+00:00",
    "headline": "Raising the bar: can higher drug spending in the UK deliver for pharma and patients?",
    "summary": "The UK considers raising NICE‚Äôs cost-effectiveness threshold, testing the balance between funding innovation and conserving NHS budget.",
    "url": "https://www.pharmaceutical-technology.com/features/raising-the-bar-can-higher-drug-spending-in-the-uk-deliver-for-pharma-and-patients/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "d34b3eed-bc1c-3739-b6e8-c7af76ed5566",
      "content": {
        "id": "d34b3eed-bc1c-3739-b6e8-c7af76ed5566",
        "contentType": "STORY",
        "title": "Raising the bar: can higher drug spending in the UK deliver for pharma and patients?",
        "description": "",
        "summary": "The UK considers raising NICE‚Äôs cost-effectiveness threshold, testing the balance between funding innovation and conserving NHS budget.",
        "pubDate": "2025-11-14T18:31:13Z",
        "displayTime": "2025-11-14T18:31:13Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/86a14b113eff4605315c4e6faf696183",
          "originalWidth": 2159,
          "originalHeight": 1388,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9.7LA6rx7zhM25C36TZ4ow--~B/aD0xMzg4O3c9MjE1OTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/pharmaceutical_technology_376/86a14b113eff4605315c4e6faf696183.cf.webp",
              "width": 2159,
              "height": 1388,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/71.wkOMWIAL0CMmqxRygeQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/86a14b113eff4605315c4e6faf696183.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/features/raising-the-bar-can-higher-drug-spending-in-the-uk-deliver-for-pharma-and-patients/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/raising-bar-higher-drug-spending-183113978.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NICE.TA"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T22:13:25+00:00",
    "headline": "Retail Investors Really Don‚Äôt Like Novo Nordisk (NVO) Stock",
    "summary": "Shares of Novo Nordisk A/S (NYSE: NVO) dropped 1.9%today, closing at $48.25, just a whisker above the 52-week low of $45.05. Sometimes we see a divergence in share price and sentiment, but with Novo Nordisk they‚Äôre actually well correlated. Discussion on Reddit has remained uniformly bearish throughout November. Novo Nordisk is trading more than 50% ... Retail Investors Really Don‚Äôt Like Novo Nordisk (NVO) Stock",
    "url": "https://247wallst.com/investing/2025/11/14/retail-investors-really-dont-like-novo-nordisk-nvo-stock/",
    "source": "24/7 Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "8a669956-3551-3065-9844-4d00fc635be2",
      "content": {
        "id": "8a669956-3551-3065-9844-4d00fc635be2",
        "contentType": "STORY",
        "title": "Retail Investors Really Don‚Äôt Like Novo Nordisk (NVO) Stock",
        "description": "",
        "summary": "Shares of Novo Nordisk A/S (NYSE: NVO) dropped 1.9%today, closing at $48.25, just a whisker above the 52-week low of $45.05. Sometimes we see a divergence in share price and sentiment, but with Novo Nordisk they‚Äôre actually well correlated. Discussion on Reddit has remained uniformly bearish throughout November. Novo Nordisk is trading more than 50% ... Retail Investors Really Don‚Äôt Like Novo Nordisk (NVO) Stock",
        "pubDate": "2025-11-14T22:13:25Z",
        "displayTime": "2025-11-14T22:13:25Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/24_7_wall_st__718/a0d3a0e2f4155ed8d8da3ce27eac142a",
          "originalWidth": 686,
          "originalHeight": 512,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rq76f8F0oZe4klQDn0Hnfw--~B/aD01MTI7dz02ODY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/24_7_wall_st__718/a0d3a0e2f4155ed8d8da3ce27eac142a.cf.webp",
              "width": 686,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ALAZXFUT9E0wT0UGpJHY3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/24_7_wall_st__718/a0d3a0e2f4155ed8d8da3ce27eac142a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "24/7 Wall St.",
          "url": "https://247wallst.com/"
        },
        "canonicalUrl": {
          "url": "https://247wallst.com/investing/2025/11/14/retail-investors-really-dont-like-novo-nordisk-nvo-stock/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/retail-investors-really-don-t-221325159.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T21:42:49+00:00",
    "headline": "Stocks to Watch Recap: Alphabet, Walmart, Eli Lilly, Warner Bros.",
    "summary": "‚ÜóÔ∏è Alphabet (GOOGL): Warren Buffett‚Äôs Berkshire Hathaway added the Google parent company to its portfolio during the third quarter, according to a new disclosure late Friday. Alphabet shares rose 1.5% afterhours.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-11-14-2025/card/stocks-to-watch-friday-applied-materials-nvidia-warner-bros--u4Yrx3bIUdt4HrktoRLp?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "61736e40-a7b9-3740-9c5c-f8ea7c76b1ed",
      "content": {
        "id": "61736e40-a7b9-3740-9c5c-f8ea7c76b1ed",
        "contentType": "STORY",
        "title": "Stocks to Watch Recap: Alphabet, Walmart, Eli Lilly, Warner Bros.",
        "description": "",
        "summary": "‚ÜóÔ∏è Alphabet (GOOGL): Warren Buffett‚Äôs Berkshire Hathaway added the Google parent company to its portfolio during the third quarter, according to a new disclosure late Friday. Alphabet shares rose 1.5% afterhours.",
        "pubDate": "2025-11-14T21:42:49Z",
        "displayTime": "2025-11-14T21:42:49Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/61736e40-a7b9-3740-9c5c-f8ea7c76b1ed/stocks-to-watch-recap-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/3cd87e4655c7a6f84655b734289e98db",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DuZVMMPCCm1AnTmbyP9ikQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/3cd87e4655c7a6f84655b734289e98db.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1zGwFFg0M3XpqvUvCEkyzA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/3cd87e4655c7a6f84655b734289e98db.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-11-14-2025/card/stocks-to-watch-friday-applied-materials-nvidia-warner-bros--u4Yrx3bIUdt4HrktoRLp?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GOOGL"
            },
            {
              "symbol": "WBD"
            },
            {
              "symbol": "UA"
            },
            {
              "symbol": "WMT"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "CMCSA"
            },
            {
              "symbol": "UAA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T21:39:20+00:00",
    "headline": "S&P 500 Posts Slight Weekly Rise, Led by Health Care, Energy",
    "summary": "The Standard & Poor's 500 index edged up 0.1% this week as gains led by health care and energy stock",
    "url": "https://finance.yahoo.com/news/p-500-posts-slight-weekly-213920671.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "73888bc4-4ca5-3fd5-b733-1ec7f935dbc7",
      "content": {
        "id": "73888bc4-4ca5-3fd5-b733-1ec7f935dbc7",
        "contentType": "STORY",
        "title": "S&P 500 Posts Slight Weekly Rise, Led by Health Care, Energy",
        "description": "",
        "summary": "The Standard & Poor's 500 index edged up 0.1% this week as gains led by health care and energy stock",
        "pubDate": "2025-11-14T21:39:20Z",
        "displayTime": "2025-11-14T21:39:20Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/p-500-posts-slight-weekly-213920671.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/p-500-posts-slight-weekly-213920671.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T18:02:00+00:00",
    "headline": "Eli Lilly Strikes Deal With Trump: Why Shares Are Up 10% Since",
    "summary": "Eli Lilly's blockbuster drug Zepbound could be getting a big new customer: Medicare. See the implications of the company's recent deal with President Trump.",
    "url": "https://www.marketbeat.com/originals/eli-lilly-strikes-deal-with-trump-why-shares-are-up-10-since/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "2d70a7e1-f8f1-382e-b9c8-ebbedddfb803",
      "content": {
        "id": "2d70a7e1-f8f1-382e-b9c8-ebbedddfb803",
        "contentType": "STORY",
        "title": "Eli Lilly Strikes Deal With Trump: Why Shares Are Up 10% Since",
        "description": "",
        "summary": "Eli Lilly's blockbuster drug Zepbound could be getting a big new customer: Medicare. See the implications of the company's recent deal with President Trump.",
        "pubDate": "2025-11-14T18:02:00Z",
        "displayTime": "2025-11-14T18:02:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/0361fb403376071db39c7d0ce0a749ad",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "Lilly logo positioned in front of Lilly's weight loss drug, mounjaro.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rLORU_C.vs4GHJgdUgRXtg--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/0361fb403376071db39c7d0ce0a749ad.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/aCEygwThV6s0odqQnKkJrQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/0361fb403376071db39c7d0ce0a749ad.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/originals/eli-lilly-strikes-deal-with-trump-why-shares-are-up-10-since/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-strikes-deal-trump-180200113.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]